Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Denali Therapeutics Inc. (DNLI)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and DNLI | ||
|---|---|---|
| S&P 500 | DNLI | |
| Start Date | Jan-01-2018 | Jan-31-2018 |
| Start Price | $2,610.60 | $23.26 |
| End Date | Sep-01-2024 | Sep-06-2024 |
| End Price | $5,520.07 | $25.25 |
| Number Monthly Prices | 81 | 81 |
| Min Date | Dec-01-2018 | Jul-31-2018 |
| Min Price | $3,185.80 | $12.59 |
| Max Date | Sep-01-2024 | Dec-31-2020 |
| Max Price | $5,520.07 | $83.76 |
| Total Return | 57.32% | 8.56% |
| Annualized Return | 6.94% | 1.22% |
| Current Value of $1,000 Purchase | $1,573 | $1,086 |
| Number Returns | 3,240 | 3,240 |
| Average Return | 17.60% | 31.09% |
| Minimum Return | -25.54% | -81.57% |
| Maximum Return | 73.27% | 565.29% |
| Number Profitable Returns | 2,656 | 1,806 |
| Percent Profitable Returns | 81.98% | 55.74% |
| Number Unprofitable Returns | 584 | 1,434 |
| Percent Unprofitable Returns | 18.02% | 44.26% |
| Profitable to Unprofitable Returns Ratio | 4.55 | 1.26 |
DNLI Performance Table and Chart
DNLI Dollar-cost Average
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates